Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin97.5%-0.1pp97.5%0.0pp97.6%+0.1pp97.6%+0.1pp97.6%+0.1pp
Net margin2.1%-1.6pp2.1%-1.4pp3.2%+1.6pp4.1%+2.5pp3.7%+2.3pp
EBITDA margin7.8%-2.0pp7.9%9%10.1%9.8%
Free cash flow margin3.4%+1.4pp4.1%2.5%1.7%2%
Returns
Return on equity10.7%-9.0pp11.2%-12.1pp18.3%+9.1pp25.6%19.7%
Return on assets2.6%
Return on invested capital14.6%
Efficiency
Asset turnover1.3×
Inventory turnover1.4×1.3×1.3×
Liquidity
Current ratio2.1×0.0×2.1×2.1×2.1×
Quick ratio0.0×1.9×1.9×
Cash ratio0.6×0.0×0.7×0.6×0.6×0.6×
Leverage
Debt-to-equity0.9×-0.1×1.8×0.9×0.9×
Debt-to-assets0.2×0.0×0.4×0.2×0.2×0.2×
Net debt / EBITDA1.1×0.0×3.3×1.1×
Interest coverage6.4×-0.9×6.2×-0.3×7.4×+3.5×8.4×7.3×
Per Share
Book value per share$9.43+12.9%$9.11+6.8%$8.77+19.9%$8.87+51.1%$8.35-5.1%
Valuation
Market capitalization$1.35B-27.8%$1.26B$1.9B
Enterprise value$1.91B-24.3%$2.92B$2.44B
Price / earnings10×+1.7×9.3×9.2×
Price / sales0.2×-0.1×0.2×0.3×
Price / book-0.6×1.5×
EV / EBITDA3.8×-0.5×5.9×4.3×
EV / sales0.3×-0.1×0.5×0.4×
Free cash flow yield16.2%+9.8pp20.5%8.3%
Earnings yield10%-2.1pp10.7%10.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Ardent Health Partners's ratios come from?
Every ratio is computed from Ardent Health Partners's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.